FindTrial
Sign In

Study from a tertiary cancer center assessing the 100 day death rate in solid cancer patients, post systemic therapy.

100 Day Mortality In Advanced Solid Malignancies- Real World Experience In A Tertiary Cancer Centre From South India. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078535
Enrollment
144
Registered
2024-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site

Interventions

Intervention1: SYSTEMIC THERAPY: CHEMOTHERAPY / IMMUNOTHERPY / TARGETED THERAPY

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ?Performance status 1-3 ECOG ?Age > 18 years ?Solid cancers ?Stage IV ?Planned for palliative sytemic treatment

Exclusion criteria

Exclusion criteria: ? Patient not eligible and not willing for systemic therapy

Design outcomes

Primary

MeasureTime frame
TO DETERMINE THE 100 DAY MORTALITYTimepoint: MORTALITY STATUS ON DAY 100 FROM THE START OF FIRST CYCLE—

Secondary

MeasureTime frame
TO STUDY FACTORS AFFECTING 100 DAY MORTALITYTimepoint: DATA COLLECTED BEFORE THE START OF TREATMENT LIKE AGE, NLR, PS, HEMOGLOBIN, ALBUMIN—

Countries

India

Contacts

Public ContactDR SHUBHA SUPRIYA A

560066

shubha30891@gmail.com9148916220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026